Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-03

FDA Approved: VOQUEZNA DUAL PAK — Original Application (Phathom Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Voquezna Dual Pak (vonoprazan fumarate and amoxicillin) from Phathom Pharmaceuticals for eradication of Helicobacter pylori infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VOQUEZNA DUAL PAK (Vonoprazan fumarate and amoxicillin)

Snippet

ORIG AP for VOQUEZNA DUAL PAK (VONOPRAZAN FUMARATE AND AMOXICILLIN)